Study of the association of docetaxel and liposomial doxorubicin Myocet in metastatic breast cancer phase II clinical trial.
Phase of Trial: Phase II
Latest Information Update: 26 May 2011
At a glance
- Drugs Docetaxel (Primary) ; Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 26 May 2011 New trial record